Innopolis Bio Innovations Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 22-12-2024
- Paid Up Capital ₹ 0.30 M
as on 22-12-2024
- Company Age 7 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.13 Cr
as on 22-12-2024
- Revenue -22.84%
(FY 2022)
- Profit -63.66%
(FY 2022)
- Ebitda -100.48%
(FY 2022)
- Net Worth 22.92%
(FY 2022)
- Total Assets 99.79%
(FY 2022)
About Innopolis Bio Innovations
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹5.13 Cr.
Shanavas Bavu, Jainendran Pillai, and Sunil Govindan serve as directors at the Company.
- CIN/LLPIN
U74999KL2017PTC051434
- Company No.
051434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Innopolis Bio Innovations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Govindan  | Director | 18-Dec-2017 | Current |
| Shanavas Bavu | Director | 18-Dec-2017 | Current |
| Jainendran Pillai | Director | 18-Dec-2017 | Current |
Financial Performance of Innopolis Bio Innovations.
Innopolis Bio Innovations Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 22.84% decrease. The company also saw a substantial fall in profitability, with a 63.66% decrease in profit. The company's net worth Soared by an impressive increase of 22.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innopolis Bio Innovations?
Unlock access to Innopolis Bio Innovations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Eten Craft Holdings Private LimitedActive 8 years 17 daysShanavas Bavu and Jainendran Pillai are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Sep 2024 | ₹2.50 Cr | Open |
Hdfc Bank Limited Creation Date: 10 Jan 2022 | ₹5.30 M | Open |
Hdfc Bank Limited Creation Date: 22 Jul 2021 | ₹1.40 Cr | Open |
How Many Employees Work at Innopolis Bio Innovations?
Innopolis Bio Innovations has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innopolis Bio Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innopolis Bio Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
